CRNO B — Cereno Scientific AB Share News
0.000.00%
Last trade - 00:00- SEK1.11bn
- SEK1.25bn
Brief: Cereno Scientific Q3 Loss After Financial Items At SEK 3 Million
Brief: Cereno Scientific Gets Approval For II Clinical Trial In Russia
Brief: Cereno Scientific Q2 Pre-Tax Loss Stable At SEK 3 Mln
Brief: Cereno Scientific Conducts Directed Issue In Connection To Oversubscribed Rights Issue
Brief: Cereno Scientific's Rights Issue Is Oversubscribed And Overallotment Issue Fully Utilized
Brief: Cereno Scientific Submits Application For Start Of Clinical Phase II Study To Bulgarian Authorities
Brief: Cereno Scientific Applies For A Patent
Brief: Cereno Scientific Appoints Daniel Brodén New CFO
Brief: Cereno Scientific Q1 Pre-Tax Loss Widens To SEK 5.3 Mln
Brief: Cereno Scientific Conducts Rights Issue Of About SEK 55.6 Million
Brief: Cereno Scientific Repays Remaining Convertible Loan
Brief: Cereno Scientific Gets Patent Approval In Australia
Brief: Cereno Scientific Repays SEK 2.6 Mln Of Convertible Loan To EHGOSF
Brief: Cereno Scientific Ends Financing Solution With European High Growth Opportunities Securitization Fund
Brief: Cereno Scientific Q4 Pre-tax Loss Widens To SEK 4.01 Mln
Brief: Cereno Scientific Recalls Tranche Of Convertible Bonds And Pauses Financing From EHGOSF
Brief: Cereno Scientific Has Issued The Seventh Tranche
Brief: Cereno Scientific: Patent Grant in US
Brief: Cereno Scientific Receives Patent Approval In US For Use Of Drug Candidate CS1